- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/125 - Picornaviridae, p. ex. calicivirus
Détention brevets de la classe A61K 39/125
Brevets de cette classe: 292
Historique des publications depuis 10 ans
|
14
|
11
|
22
|
24
|
13
|
20
|
11
|
20
|
25
|
14
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Takeda Vaccines, Inc. | 220 |
25 |
| Vactech Oy | 14 |
13 |
| Beijing Minhai Biotechnology Co., Ltd | 16 |
8 |
| Denka Company Limited | 2650 |
6 |
| Boehringer Ingelheim Animal Health USA Inc. | 421 |
6 |
| Boehringer Ingelheim Vetmedica, Inc. | 111 |
5 |
| Glaxosmithkline Biologicals S.A. | 1652 |
5 |
| Novartis Vaccines and Diagnostics, Inc. (a Delaware corporation) | 26 |
4 |
| Wisconsin Alumni Research Foundation | 3890 |
4 |
| The Trustees of the University of Pennsylvania | 4376 |
4 |
| Mayo Foundation for Medical Education and Research | 3286 |
4 |
| Case Western Reserve University | 1844 |
4 |
| Children's Hospital Medical Center | 735 |
4 |
| Modernatx, Inc. | 1296 |
4 |
| Ip2ipo Innovations Limited | 173 |
4 |
| Curevac SE | 275 |
4 |
| Duke University | 3106 |
3 |
| Icon Genetics GmbH | 46 |
3 |
| Lanzhou Veterinary Research Institute Chinese Academy of Agricultural Sciences | 30 |
3 |
| National Health Research Institutes | 328 |
3 |
| Autres propriétaires | 176 |